Skip to main content
Pamela (Pierce) Palmer, MD, Anesthesiology, San Francisco, CA

PamelaP.(Pierce)PalmerMDPhD

Anesthesiology San Francisco, CA

Pain Medicine, Pediatric Pain Medicine

Chief Medical Officer and Co-Founder, AcelRx Pharmaceuticals

Dr. Palmer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Palmer's full profile

Already have an account?

  • Office

    2255 Post St
    San Francisco, CA 94115
    Phone+1 415-885-7246
    Fax+1 415-885-7575

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Pain Medicine, 1996 - 1997
  • Santa Clara Valley Medical Center
    Santa Clara Valley Medical CenterInternship, Transitional Year, 1992 - 1993
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1992

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1994 - 2026
  • American Board of Anesthesiology Anesthesiology

Publications & Presentations

PubMed

Press Mentions

  • AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Patients Taking Buprenorphine Who Require a Surgical Procedure
    AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Patients Taking Buprenorphine Who Require a Surgical ProcedureApril 8th, 2021
  • AcelRx Pharmaceuticals : Announces an Investigator-Initiated Study of DSUVIA® in Cardiac Surgery Enhanced Recovery Regimen
    AcelRx Pharmaceuticals : Announces an Investigator-Initiated Study of DSUVIA® in Cardiac Surgery Enhanced Recovery RegimenJanuary 19th, 2021
  • AcelRx Pharmaceuticals : Announces an Investigator-Initiated Study of DSUVIA® in Orthopedic Patients in the Perioperative Setting
    AcelRx Pharmaceuticals : Announces an Investigator-Initiated Study of DSUVIA® in Orthopedic Patients in the Perioperative SettingAugust 24th, 2020
  • Join now to see all

Grant Support

  • Transcription Regulation &Interaction Of ORL1 And GAIPNational Institute Of Neurological Disorders And Stroke2004–2007
  • Nociceptin &Orl1 Receptor In Synovial Inflammation/PainNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2003
  • Subcutaneous Infusion Of Sufentanil Citrate For PainNational Center For Research Resources2000–2002
  • 5-HT Receptors--Peripheral Pain And InflammationNational Institute Of Neurological Disorders And Stroke1997–2001
  • 5HT Receptors--Peripheral Pain And InflammationNational Institute Of Neurological Disorders And Stroke1999